The Pharmacy Times® Zoster Resource Center is a comprehensive resource for clinical news and expert insights on the reactivation of the chickenpox virus in the body, which causes a painful rash.
March 17th 2023
Staff members, especially immunizers, should look at every encounter as an opportunity to educate, support patients.
Study: Primary COVID-19 Vaccines Found to Not Increase Risk of Herpes ZosterNovember 22nd 2022
Subgroup analyses suggest that a primary dose of the COVID-19 vaccine does not increase risk of herpes zoster infection, regardless of age, immunocompromised status, and type of vaccine administered.
Study: Antibiotics May Influence Reactivation of Varicella Zoster VirusNovember 8th 2022
Tetracyclines have been shown to offer some degree of immune protection resulting in mucosal healing, and in this study, they had one of the smaller associations with herpes zoster.
Expert: Long-term Care Industry Needs Help of Pharmacists to Improve Infection Prevention, ControlNovember 7th 2022
A session presenter at the ASCP 2022 Annual Meeting explained how the COVID-19 pandemic significantly magnified the importance of infection prevention and control practices in long-term care.
Letermovir Shows Efficacy Preventing Cytomegalovirus Disease in Adults After Kidney TransplantationOctober 26th 2022
The objective of the trial was to compare letermovir with valganciclovir in preventing CMV disease in adults who received a kidney transplant and who are at high risk for CMV disease.
Data Show Shingrix Offers 10 Years of Protection Against Shingles in Adults 50 Years of Age and OlderOctober 25th 2022
The efficacy of Shingrix was 97% in adults 50 years of age and older and 91% in adults 70 years of age and older over an extended follow-up period.
Central Nervous System Infection Is Common in Multiple Strains of HerpesvirusOctober 24th 2022
Researchers conducted a review all 8 herpesviruses and their known treatments and found patients experienced encephalitis or another CNS symptom in almost every strain.
Study: Health Care Professionals Should Recommend Herpes Zoster Vaccine for Patients With COPDOctober 18th 2022
A short 5-minute educational video may improve health care professionals’ knowledge about the herpes zoster vaccine, guidelines, and what patients should receive it.
Study: Encouraging Vaccination Can Minimize Shingles, Chickenpox Incidence to Reduce Varicella Zoster Virus Transmission, ReactivationOctober 11th 2022
The initial VZV infection results in chickenpox, whereas viral reactivation following a period of dormancy manifests as shingles.
Tofacitinib, Biologic DMARDs Associated with Higher Risk of Herpes Zoster in Patients with Rheumatoid ArthritisAugust 15th 2022
Treatment with biologic disease-modifying antirheumatic drugs associated with a higher overall risk, incidence, and recurrence of herpes zoster for patients with rheumatoid arthritis.
Study: General Practitioners Lack Understanding of Zoster Vaccine Risks, Guidelines for Immunocompromised PatientsJuly 15th 2022
Researchers found knowledge gaps among general practitioners regarding the administration of Zostavax, particularly for contraindicated patients who are immunocompromised.
Updated Recombinant Zoster Vaccine Recommendations Accepted by Physicians, but Knowledge Gaps, Financial Barriers PersistJuly 12th 2022
Though most primary care physicians indicate a willingness to accept expanded recommendations from the Advisory Committee on Immunization Practice suggesting administration of recombinant zoster vaccine for adult patients who are immunocompromised, cost concerns and knowledge gaps limit vaccine delivery.